LAMP1 and neoplasm: CD107a is a degranulation marker expressed during the degranulation response of CD8T cells, suggesting that the intra-lymph node administration of DC2.4 pulsed with tumor lysate and VP-R8 could enhance the membrane permeability of tumor antigens and induce more activated CD8T cells in the tumor to eliminate tumor cells.